Download PDF
Dtsch Med Wochenschr 2016; 141(19): 1404-1406
DOI: 10.1055/s-0042-110616
Standpunkt
© Georg Thieme Verlag KG Stuttgart · New York

Polio-Impfung

Eine StandortbestimmungPolio vaccination – where we stand now
Hans E. Müller
Further Information

Publication History

Publication Date:
29 August 2016 (online)

Also available at
    Permissions and Reprints

Das Ziel, die Polio auszurotten, rückt immer weiter in die Ferne. Das liegt nicht zuletzt auch am empfohlenen Totimpfstoff. Denn dieser verursacht keine Darmimmunität – und so können geimpfte Personen in Endemiegebieten jahrelang unbemerkt Polioviren ausscheiden. Durch die Flüchtlingskrise wächst die Gefahr, dass die Viren auf diese Weise auch in poliofreie Gebiete eingeschleppt werden.

Schlüsselwörter

Polioimpfung - OPV - IPV - Eradikation - Kontrolle

Keywords

polio vaccination - OPV - IPV - eradication - control
 

  • Literatur

  • 1 Sutter RW, Suleiman AJM, Malankar P et al. Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med 2000; 343: 767-773
    CrossrefPubMedGoogle Scholar
  • 2 Modin JF. The bumb road to polio eradication. N Engl J Med 2010; 362: 2346-2349
    CrossrefPubMedGoogle Scholar
  • 3 Evans AS. Criteria for assessing accomplishment of poliomyelitis control. Rev Infect Dis 1984; 6: S571-576
    CrossrefPubMedGoogle Scholar
  • 4 Arya SC. Hiding polioviruses. Lancet 2003; 361: 2156-2157
    PubMedGoogle Scholar
  • 5 Macadam AJ, Arnold C, Howlett J et al. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccines. Virology 1989; 172: 408-414
    CrossrefPubMedGoogle Scholar
  • 6 Minor PD. Attenuation and reversion of the Sabon vaccine strains of poliovirus. Dev Biol Standard 1993; 78: 17-26
    PubMedGoogle Scholar
  • 7 Friedrich F. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy vontacts and healthy vaccinees. Acta Virol 1996; 40: 157-170
    PubMedGoogle Scholar
  • 8 Melnick JL. Poliomyelitis vaccination – what are the options. Clin Immunother 1996; 6: 1-6
    CrossrefPubMedGoogle Scholar
  • 9 Beale AJ. Efficacy and safety of oral poliovirus vaccine and inactivated poliovirus vaccine. Pediatr Infect Dis J 1991; 10: 970-972
    CrossrefPubMedGoogle Scholar
  • 10 Dove AW, Racaniello VR. The polio eradication effort: should vaccine eradication be next?. Science 1997; 277: 779-780
    CrossrefPubMedGoogle Scholar
  • 11 Kew OM, Wright PF, Agol VI et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull WHO 2004; 82: 16-23
    PubMedGoogle Scholar
  • 12 Anonymus: La région Europe de l’OMS indemne de poliomyélite / The WHO european region declard free of polio. Eurosurveillance 2002; 7: 76-77
    PubMedGoogle Scholar
  • 13 Cochi SL, Linkins RW. The finale phase of polio eradication: new vacines and complex choices. J. Infect Dis 2012; 205: 169-171
    CrossrefPubMedGoogle Scholar
  • 14 [Anonym]. Update on vaccine-derived poliovirusus – worldwide, July 2012 -December 2013. MMWR 2014; 63: 242-248
    PubMedGoogle Scholar
  • 15 [Anonym]. Global polio eradication initiative. Polio this week as of 23 March 2016. http://www.polioeradication.org/Dataandmonitoring/poliothisweek.aspx Letzter Zugriff: 21.06.2016
    PubMed
  • 16 Yang C-F, Naguib T, Yang S-J et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt. J Virol 2003; 77: 8366-8377
    CrossrefPubMedGoogle Scholar
  • 17 Shimizu H, Thorley B, Paladin FJ et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines. J Virol 2004; 78: 13512-13521
    CrossrefPubMedGoogle Scholar
  • 18 Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandressy R et al. Recombinant vaccine-derived polioviris in Madagascar. Emerg Infect Dis 2003; 9: 885-887
    CrossrefPubMedGoogle Scholar
  • 19 Rakoto-Andrianarivelo M, Gumede N Jegouic et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 2008; 197: 1427-1437
    CrossrefPubMedGoogle Scholar
  • 20 Ling X, Zhang Y, Xu W et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis 2006; 194: 545-551
    CrossrefPubMedGoogle Scholar
  • 21 Gumede N, Lentsoane O, Burns CC et al. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004–2011. Emerg Infect Dis 2013; 19: 1583-1589
    CrossrefPubMedGoogle Scholar
  • 22 Jenkins HE, Aylward RB, Gasasira A et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010; 362: 2360-2369
    CrossrefPubMedGoogle Scholar
  • 23 Roberts L. The art of eradicating polio. Science 2013; 342: 29-35
    PubMedGoogle Scholar
  • 24 Estivariz CF, Watkins MA, Handoko D et al. A large vaccine-derived poliovirus outbreak on Madura Island-Indonesia. 2005. J Infect Dis 2008; 197: 347-354
    CrossrefPubMedGoogle Scholar
  • 25 [Anonym]. Progress towards poliomyelitis eradication – Egypt, 2003–2004. MMWR 2004; 53: 820-822
    PubMedGoogle Scholar
  • 26 Lösch R, Klare U. Poliomyelitis breitet sich in Ostafrika aus. Flug-, Tropen- Reisemed 2013; 20: 213
    PubMedGoogle Scholar
  • 27 [Anonym]. Outbreak of polio in adults – Namibia, 2006. MMWR 2006; 55: 1198-1201
    PubMedGoogle Scholar
  • 28 [Anonym]. Outbreaks following wild poliovirus importations – Europe, Africa, and Asia, January 2009 – September 2010. MMWR 2010; 59: 1393-1399
    PubMedGoogle Scholar
  • 29 Luo H-M, Zhang Y, Wang X-Q et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med 2013; 369: 1981-1990
    CrossrefPubMedGoogle Scholar
  • 30 [Anonym]. Progress towards poliomyelitis eradication – Afghanistan, January 2012 – September 2013. MMWR 2013; 62: 928-933
    PubMedGoogle Scholar
  • 31 Roberts L. Israels’s silent polio epidemic breaks all the rules. Science 2013; 342: 679-680
    CrossrefPubMedGoogle Scholar
  • 32 Tulchinsky TH, Ramlawi A, Abdeen Z et al. Polio lessons 2013: Israel, the West Bank, and Gaza. Lancet 2013; 382: 1611-1612
    CrossrefPubMedGoogle Scholar
  • 33 Herremans T, Kimman TG, Conyn-van Spaendonck MAE et al. Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population. Clin Infect Dis 2002; 34: 1067-1075
    CrossrefPubMedGoogle Scholar
  • 34 [Anonym]. Importation of wild poliovirus in environmental (sewage) samples in Egypt. http://http://www.emro.who.int/polio/polio-news/new-polio-virus-egypt.html Letzter Zugriff: 21.06.2016
    PubMedGoogle Scholar
  • 35 Mohammadi D. Middle Easern countries scramble to stop spread of polio. Lancet 2013; 382: 1621-1622
    CrossrefPubMedGoogle Scholar
  • 36 Rutter PD, Donaldson LJ. Mandatory poliovaccination for travellers: protecting global public health. Lancet 2014; 383: 1695-1696
    CrossrefPubMedGoogle Scholar
  • 37 Eichner M, Brockmann SO. Polio emergence in Syria and Israel endangers Europe. Lancet 2013; 382: 1777
    PubMedGoogle Scholar
  • 38 Celentano LP, Lopalco PL, Hitric E et al. Polio and the risk for the European Union. Lancet 2014; 383: 216-217
    PubMedGoogle Scholar
  • 39 Mundel T, Orenstein WA. No country is safe without global erdadication of poliomyelitis. N Engl J Med 2013; 369: 2045-2046
    CrossrefPubMedGoogle Scholar
  • 40 Razum O, Müller O. Polio eradication: where are we now?. Lancet 2013; 382: 1979
    PubMedGoogle Scholar
  • 41 Lycke E, Magnius LO, Norder H. Should we use oral polio vaccine in Europe?. Lancet 2014; 383: 1037-1038
    CrossrefPubMedGoogle Scholar
  • 42 Bancroft EA, Carillo-Santisvere P, Celentano LP et al. Author’s reply. Lancet 2014; 383: 1038
    CrossrefPubMedGoogle Scholar
  • 43 Riedl-Seifert R. Praxisferne Überlegungen setzen Erfolg aufs Spiel. Schluckimpfung passé – ein Fehler. Ärztl Praxis Nr 54 7.7.2000
    PubMedGoogle Scholar
  • 44 Thompson KM, Tebbens RJD. Eradication versus control for poliomyelitis: an economic analysis. Lancet 2007; 369: 1363-1371
    CrossrefPubMedGoogle Scholar
  • 45 Babadoko S. Sharia body wants polio vaccination suspended – Says it contains anti-pregnancy agents. Daily Trust 28.07.2003
    PubMedGoogle Scholar
  • 46 [Anonym]. Polio eradication: the CIA and their unintended victims. Lancet 2014; 383: 1862
    PubMedGoogle Scholar
  • 47 Fish EN, Flanagan KL, Furman D et al. Changing oral vaccine to inactivated poliovaccine might increase mortality. Lancet 2016; 387: 1054-1055
    PubMedGoogle Scholar
  • 48 Müller HE. Pockenimpfung – Plädoyer für eine Wiedereinführung. Dtsch Ärztebl 2004; 101: A2090-2091
    PubMedGoogle Scholar
  • 49 Lund N, Andersen A, Hansen AS et al. The effect of oral polio vaccine at birth on infant mortality: a randomized trial. Clin Infect Dis 2015; 61: 1504-1511
    CrossrefPubMedGoogle Scholar
  • 50 Aaby P, Garly ML, Nielsen J et el. Increased female-male mortality ratio asssociated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J 2007; 26: 247-252
    CrossrefPubMedGoogle Scholar